Table 1.
Cellular micro ribonucleic acids deregulated by human papillomavirus proteins
HPV protein
|
miRNA target
|
miRNA expression level
|
Sample type
|
Biological effect(s)
|
Ref.
|
E5 | miR-146a | + | E5-expressing HaCat cells | Promoted cell proliferation | [106] |
miR-203 | - | E5-expressing HaCat cells | Increased expression of p63 | [106] | |
miR-324-5p | - | E5-expressing HaCat cells | Contributed to cervical carcinogenesis | [106] | |
E6 | miR-20a | + | CaSki and SiHa (HPV16+) human cervical cell lines | Promoted cell growth through downregulating PDCD6 and activating Akt and p38 | [156] |
miR-20b | + | HeLa (HPV18+), SiHa and Caski human cervical cancer cell lines; Cervical carcinoma tissues | Reduced TIMP2 expression and induced EMT, migration, and invasion | [157] | |
miR-23b | - | SiHa and CaSki cell lines | Increased expression of uPA and induction of migration in human cervical cancer cells | [158] | |
miR-30c-2* | - | HPV-infected NSCLC; TL1 cell line | Correlated with tumor stage and lymph node metastasis | [159] | |
miR-34a | - | CaSki and SiHa cell lines, HPV18-positive cell lines HeLa and C411, HPV68-positive cell line ME180Cervical cancer tissues | Inhibited cell proliferation; Increased LDHA expression levels, inhibited Warburg effect and reprogrammed glycolysis through targeting LDHA | [160,161] | |
miR-145 | - | Hela, SiHa, and CaSki cell lines; Cervical cancer tissues | Modulated invasion and therapy resistance of cervical cancer cells | [162] | |
miR-195 | - | HeLa and SiHa cell line cervical cancer tissue samples | Promoted cell proliferation, invasion, and metastasis | [163] | |
miR-218 | - | HPV16 positive cervical cell lines and tissues; Cervical cancer tissues | Increased expression of LAMB3, SFMFBT1, and DCUN1D1, promoted EMT, migration, and invasion in cervical cancer associated with clinicopathological characteristics of patients | [164,165] | |
miR-375 | - | SiHa and CaSki cell lines; Cervical tissue samples | Modulated EMT in cervical cancer; Enhanced invasion and metastasis of cervical carcinoma cells through targeting SP1 | [166,167] | |
miR-2861 | - | SiHa and CaSki cell lines; Cervical cancer tissues | Enhanced cell proliferation and invasion, and inhibited apoptosis in cervical cancer cells; Negatively associated with advanced tumor stage and lymph node metastasis | [168] | |
E7 | miR-15b | + | HPV16 E7-expressing tumors from anal carcinoma patients; CaSki cell line | Downregulated cyclin E1; Increased expression of several E2F-regulated genes | [111] |
miR-20a | + | OSCC tissues | Inhibited cell proliferation, invasion, and migration | [169] | |
miR-21 | + | HPV16 E7-transfected Hela cells; Cervical cancer tissue | Enhanced cervical carcinoma cell proliferation, growth, and invasion; Involved in cervicitis and cervical cancer progression | [170,171] | |
miR-25 | + | HVK-derived raft tissues infected with either HPV16 or HPV18 | Increased expression correlated with the progression of the cervical lesions, making it a potential biomarker for CINs and cervical cancer | [96] | |
miR-27b | + | HPV 16-positive human cervical carcinoma tissues; SiHa and CaSki cell lines | Reduced PLK2 expression; Promoted cell proliferation and inhibited paclitaxel-induced cell apoptosis; Inhibited PPARγ expression and promoted proliferation and invasion | [172,173] | |
miR-205 | + | HPV-positive keratinocytes | Activated Akt pathway and upregulated cyclin D1 levels, resulting in increased proliferation | [174] | |
miR-323 | + | Cervical cancer cell lines transfected with HPV 16 E7 and SiHa cervical cancer cells | --- | [175] | |
E6/E7 | miR-16 | + | HFK-derived raft cultures with HPV16 infection; HVK-derived raft tissues infected with either HPV16 or HPV18; CIN3 and Cervical carcinoma tissues with HR HPV infection | --- | [96] |
miR-22 | - | HVK-derived raft tissues infected with either HPV16 or HPV18 | Suppressed tumor growth and metastasis | [96,176] | |
miR-24 | + | HPV-positive keratinocytes | Reduced p27 expression level and enhanced proliferation | [174] | |
miR-29a | - | HVK-derived raft tissues infected with either HPV16 or HPV18 | --- | [96] | |
miR-92a | + | CIN and cervical carcinoma tissues with HR HPV infection, and raft tissues with HPV16 or HPV18 infection | Increased expression correlated with the progression of the cervical lesions, and may serve as a biomarker for CINs and cervical cancer | [96] | |
miR-100 | - | HFK-derived raft cultures with HPV18 infection | --- | [96] | |
miR-125a | - | Cervical carcinoma tissuesSiHa and HeLa cell lines | Increased STAT3 expression and enhanced tumorigenesis and metastasis | [177] | |
miR-146a-5p | - | HPV16 E6/E7-positive keratinocytes; Hela, SiHa, and CaSki cell lines | Enhanced expression of KDM2B; Promoted proliferation and migration | [178] | |
miR-203 | - | NHKs and NFKs expressing E6, E7, or combination | Increased expression of p63 and promotion of cell proliferation | [179,180] | |
miR-378 | + | CIN3 and cervical carcinoma tissues with HR HPV infection, and raft tissues with HPV16 or HPV18 infection | --- | [96] |
“+”: Upregulated; “-”: Downregulated; miRNAs: Micro ribonucleic acid; HPV: Human papillomavirus; PDCD6: Programmed cell death 6; TIMP-2: Tissue inhibitor of metalloproteinase 2; EMT: Epithelial to mesenchymal transition; NSCLC: Non-small cell lung cancer; LDHA: Lactate dehydrogenase A; LAMB3: Laminin 5 β3; SFMFBT1: Scm-like with four MBT domains 1; DCUN1D1: Defective in cullin neddylation 1; Domain containing 1; OSCC: Oral squamous cell carcinoma; HVK: Human vaginal keratinocytes; PLK2: Polo-like kinase2; CIN: Cervical intraepithelial neoplasia; HFK: Human foreskin keratinocytes; CIN3: Cervical intraepithelial neoplasia 3; HR HPV: High risk HPV.